Our 2018 Fall Summit, which will be held in Manchester, New Hampshire on September 19-20, is fast approaching! With a focus on regulatory as well as education and workforce development initiatives, paired with a unique agenda that promotes collaboration and discussion amongst attendees, this event will be one that you will not want to miss. Speakers will provide insight and perspectives from industry, government, academia and non-profit from within the US and abroad with a large number of opportunities for networking amongst the growing ecosystem. For the most up-to-date information on the agenda, please visit our event page.
According to Mary Stewart, Director of Education and Workforce Development at ARMI | BioFabUSA, the 2018 Fall Summit is of great importance. “As the technology within this nascent industry continues to evolve, it is essential that we start thinking about the skills that will be needed for individuals pursuing a career in tissue engineering and regenerative medicine. The Summit brings together the technology, regulatory and standards perspective as well as workforce initiatives and shows their interconnectedness and dependability on one another, which will in turn allow us to develop a prepared workforce. One that has been created alongside these new technologies so that we are able to manufacture tissues and organs at a large-scale.”
Attendance is quickly growing, and with limited space available, it is important to register now! General registration is only $299, with a price that is set to increase after August 31st. Discounts are available exclusively to members of the ARMI | BioFabUSA community – reach out to your Account Manager for more information on how you can take advantage of this offer.
Attendees are also encouraged to secure their overnight accommodations at the Manchester Downtown Hotel using the following link.
In addition to connecting with other attendees at the conference, there are also opportunities to sponsor and exhibit at the 2018 Fall Summit. Spots are limited and are available on a first come first serve basis. If you would like more information, please contact firstname.lastname@example.org.
Dr. Richard McFarland, Chief Regulatory Officer at ARMI | BioFabUSA believes that, “We are at an inflection point for regenerative medicine with scientific findings, government funding initiatives, and innovative regulatory approaches coalescing to produce a pluripotent primordial soup from which an industry can arise. Leaders from FDA, Peter Marks, NIH Amy Paterson and HHS, Sandeep Patel will be here to discuss this nexus of activities. I am looking forward to seeing you here as well.”